Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Puhekupla
    Junior Member
    • Feb 2014
    • 8

    #1

    Illumina MiSeq read orientiation

    Hi all,
    I've got RNA-seq paired-end Illumina MiSeq data. I'm stuck with which read now represents the forward strand, and which one the reverse complement strand. When mapping, which read (R1/R2) should map (equals part of) to the 5' -> 3' reference sequence? And which one should map to its reverse complement?

    [Header]
    IEMFileVersion,4
    Experiment Name,sampleA
    Date,12/10/2013
    Workflow,GenerateFASTQ
    Application,RNA-Seq
    Assay,TruSeq LT
    Description,
    Chemistry,Default
    Last edited by Puhekupla; 02-26-2014, 04:03 AM.
  • mastal
    Senior Member
    • Mar 2009
    • 666

    #2
    Unless the library-prep was done using a strand-specific protocol,
    the reads will map to both strands.

    In the Illumina system, the two reads of a pair, R1 and R2, will map to different strands.

    Comment

    • Puhekupla
      Junior Member
      • Feb 2014
      • 8

      #3
      Yes, but which one of the pair maps to the forward reference sequence, and which one to the reverse complement? (Or should).
      Last edited by Puhekupla; 02-26-2014, 04:11 AM.

      Comment

      • relipmoc
        Member
        • Jul 2011
        • 58

        #4
        Originally posted by Puhekupla View Post
        Yes, but which one of the pair maps to the forward reference sequence, and which one to the reverse complement? (Or should).
        For each pair, one read will be mapped to one strand of the reference genome, the other will be mapped to the other strand of the reference genome (i.e. reverse complementary to the first strand). So you question can be translated into "will the first read of a pair definitely be mapped to the positive strand of the reference genome or definitely be mapped to the negative strand of the reference genome?". Of course, the answer is NO.

        Comment

        • bernardo_bello
          Member
          • May 2012
          • 49

          #5
          In my case:

          R2 is the forward
          R1 is the reverse

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Today, 10:13 AM
          0 responses
          10 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          19 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          17 views
          0 reactions
          Last Post SEQadmin2  
          Working...